Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
Key Facts
Company highlights
214+
$109.9M
$2.7B
46K+
Information reflects FY23 data
Therapies and services for insulin-dependent people who have Type 1 and Type 2 diabetes
Gastrointestinal
Patient Monitoring
Renal Care Solutions
Respiratory Interventions
Surgical Innovations
Surgical Robotics
Cranial and Spinal Technologies
Neuromodulation
Neurovascular
Pelvic Health and Gastric Therapies
Ear, Nose, and Throat
Explore topics: